This week’s topics include two papers comparing everolimus-eluting stents and CABG and a study of short-term exposure to air pollution and stroke.
Jean-Pierre Usdin is frustrated with his “Tobacco-Free” hospital’s accommodations for smokers that encourage them to keep smoking instead of supporting them to quit.
The PROMISE trial, which was presented and discussed in a Journal Club forum at ACC.15, prompted some interesting discussion when CardioExchange covered it as a news story on March 14. Dr. Daniel B. Mark, one of the PROMISE investigators, now sheds further light on the trial in response to questions from CardioExchange news writer Larry…
This week’s topics include antiplatelet therapy duration following bare metal or drug-eluting coronary stents, thrombolysis in acute ischemic stroke, and more.
Saurav Chatterjee reports from the 2015 ACC conference with even more exciting opportunities for fellows in training and other health care professionals.
Saurav Chatterjee reports on exciting opportunities for fellows in training available at the 2015 ACC conference.
This week’s topics include endovascular therapy for ischemic stroke with perfusion-imaging selection, innovation and implementation in CV medicine, statin intolerance, and more.
Sripal Bangalore discusses his observational study comparing CABG with everolimus-eluting stent PCI in patients with multivessel coronary disease, alongside findings from the BEST randomized trial.
As ACC.15 unfolds, check our Headquarters page for all of our latest coverage!
Pamela S. Douglas discusses the PROMISE randomized comparison of CT angiography with functional exercise testing in more than 10,000 patients with chest pain.